Tariku Mandaras, Ali Tilahun, Misgana Tadesse, Hajure Mohammedamin, Asfaw Henock
Department of Psychiatry, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Department of Psychiatry, College of Health and Medical Sciences, Mettu University, Mettu, Ethiopia.
Depress Res Treat. 2021 Feb 9;2021:6697339. doi: 10.1155/2021/6697339. eCollection 2021.
Depression is a significant contributor to the global burden of disease and affects all individuals throughout their lifetime. Patients with schizophrenia are frequently attacked by depression during their total illness duration. Presence of comorbid depression in schizophrenia makes the patients more deteriorating and disabling course and poor outcome. . To determine the prevalence of depression and highlight the associated sociodemographic and clinical factors in patients with schizophrenia in a specialized hospital in Addis Ababa, Ethiopia. . This study was conducted at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia.
An institutional based cross-sectional study was conducted from May to June 2018. Depression was measured by Calgary Depression Scale for Schizophrenia on 455 samples of patient with schizophrenia and systematic sampling was used to select the study participants. Oslo Social Support Scale and Alcohol, Smoking, and Substance Involvement Screening Test were used to assess social support and substance use factors, respectively. A bivariable and multivariable logistic regression analysis model was performed to control the confounding factors. Odds ratio (OR) with the corresponding 95% confidence interval (95% CI) was determined to evaluate the strength of association.
A total of 445 patients responded to the questionnaire, which yields a response rate of 97.8%. The Magnitude of depression among schizophrenia patients was 24.9%. A multivariable logistic regression analysis model showed that being female [AOR 2.00, 95% CI: 1.25-3.18], divorced/widowed [AOR 2.39, 95% CI: 1.04-5.49], current substance use [AOR 1.95, 95% CI: 1.17-3.25], and poor social support [AOR 2.75, 95% CI: 1.35-5.61] were significantly associated with depression in schizophrenia.
The magnitude of depression among schizophrenia was 24.9%. Being female, divorced/widowed, current substance use, and poor social support were associated with depression among patients with schizophrenia. Regular screening and prompt management of depressive symptoms among patients with schizophrenia is of particular importance to reduce the burden of the condition.
抑郁症是全球疾病负担的重要因素,影响着所有人的一生。精神分裂症患者在整个病程中经常受到抑郁症的侵袭。精神分裂症合并抑郁症会使患者的病情更加恶化、致残,预后更差。为了确定埃塞俄比亚亚的斯亚贝巴一家专科医院中精神分裂症患者抑郁症的患病率,并突出相关的社会人口学和临床因素。本研究在埃塞俄比亚亚的斯亚贝巴的阿马努埃尔精神专科医院进行。
2018年5月至6月进行了一项基于机构的横断面研究。采用卡尔加里精神分裂症抑郁量表对455例精神分裂症患者进行抑郁测量,并采用系统抽样方法选择研究参与者。分别使用奥斯陆社会支持量表和酒精、吸烟及物质使用筛查测试来评估社会支持和物质使用因素。进行双变量和多变量逻辑回归分析模型以控制混杂因素。确定比值比(OR)及相应的95%置信区间(95%CI)以评估关联强度。
共有445名患者对问卷做出回应,回应率为97.8%。精神分裂症患者的抑郁程度为24.9%。多变量逻辑回归分析模型显示,女性[AOR 2.00,95%CI:1.25 - 3.18]、离婚/丧偶[AOR 2.39,95%CI:1.04 - 5.49]、当前物质使用[AOR 1.95,95%CI:1.17 - 3.25]以及社会支持差[AOR 2.75,95%CI:1.35 - 5.61]与精神分裂症患者的抑郁症显著相关。
精神分裂症患者中抑郁症的程度为24.9%。女性、离婚/丧偶、当前物质使用以及社会支持差与精神分裂症患者的抑郁症相关。对精神分裂症患者进行定期筛查和及时管理抑郁症状对于减轻病情负担尤为重要。